BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 24013023)

  • 1. A review of the current understanding and clinical utility of miRNAs in esophageal cancer.
    Sakai NS; Samia-Aly E; Barbera M; Fitzgerald RC
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):512-21. PubMed ID: 24013023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis.
    Leidner RS; Ravi L; Leahy P; Chen Y; Bednarchik B; Streppel M; Canto M; Wang JS; Maitra A; Willis J; Markowitz SD; Barnholtz-Sloan J; Adams MD; Chak A; Guda K
    Genes Chromosomes Cancer; 2012 May; 51(5):473-9. PubMed ID: 22302717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.
    Yang H; Gu J; Wang KK; Zhang W; Xing J; Chen Z; Ajani JA; Wu X
    Clin Cancer Res; 2009 Sep; 15(18):5744-52. PubMed ID: 19737949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
    Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
    Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus.
    Craig MP; Rajakaruna S; Paliy O; Sajjad M; Madhavan S; Reddy N; Zhang J; Bottomley M; Agrawal S; Kadakia MP
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00125. PubMed ID: 31934893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
    Wu X; Ajani JA; Gu J; Chang DW; Tan W; Hildebrandt MA; Huang M; Wang KK; Hawk E
    Cancer Prev Res (Phila); 2013 Mar; 6(3):196-205. PubMed ID: 23466817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA Expression Signatures During Malignant Progression From Barrett's Esophagus.
    Bansal A; Gupta V; Wang K
    J Cell Biochem; 2016 Jun; 117(6):1288-95. PubMed ID: 26808728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the unique microRNA signature in human esophageal adenocarcinoma.
    Saad R; Chen Z; Zhu S; Jia P; Zhao Z; Washington MK; Belkhiri A; El-Rifai W
    PLoS One; 2013; 8(5):e64463. PubMed ID: 23724052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer.
    Garman KS; Owzar K; Hauser ER; Westfall K; Anderson BR; Souza RF; Diehl AM; Provenzale D; Shaheen NJ
    Dig Dis Sci; 2013 Nov; 58(11):3178-88. PubMed ID: 23925817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma.
    Nguyen GH; Schetter AJ; Chou DB; Bowman ED; Zhao R; Hawkes JE; Mathé EA; Kumamoto K; Zhao Y; Budhu A; Hagiwara N; Wang XW; Miyashita M; Casson AG; Harris CC
    Clin Cancer Res; 2010 Dec; 16(23):5824-34. PubMed ID: 20947516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
    Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
    World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.
    Drahos J; Schwameis K; Orzolek LD; Hao H; Birner P; Taylor PR; Pfeiffer RM; Schoppmann SF; Cook MB
    Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):429-37. PubMed ID: 26604271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases.
    Kazeminezhad B; Mirafsharieh SA; Dinyari K; Azizi D; Ebrahimi A
    Turk J Gastroenterol; 2014 Jun; 25(3):253-6. PubMed ID: 25141312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer.
    Hemmatzadeh M; Mohammadi H; Karimi M; Musavishenas MH; Baradaran B
    Biomed Pharmacother; 2016 Aug; 82():509-19. PubMed ID: 27470391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus.
    Smith CM; Watson DI; Leong MP; Mayne GC; Michael MZ; Wijnhoven BP; Hussey DJ
    World J Gastroenterol; 2011 Feb; 17(8):1036-44. PubMed ID: 21448356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus.
    Maru DM; Singh RR; Hannah C; Albarracin CT; Li YX; Abraham R; Romans AM; Yao H; Luthra MG; Anandasabapathy S; Swisher SG; Hofstetter WL; Rashid A; Luthra R
    Am J Pathol; 2009 May; 174(5):1940-8. PubMed ID: 19342367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study.
    Revilla-Nuin B; Parrilla P; Lozano JJ; de Haro LF; Ortiz A; Martínez C; Munitiz V; de Angulo DR; Bermejo J; Molina J; Cayuela ML; Yélamos J
    Ann Surg; 2013 May; 257(5):886-93. PubMed ID: 23059500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of miRNAs and genes for predicting Barrett's esophagus progressing to esophageal adenocarcinoma using miRNA-mRNA integrated analysis.
    Yao C; Li Y; Luo L; Xiong Q; Zhong X; Xie F; Feng P
    PLoS One; 2021; 16(11):e0260353. PubMed ID: 34818353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers.
    Bobryshev YV; Orekhov AN; Chistiakov DA
    Curr Pharm Des; 2015; 21(23):3402-16. PubMed ID: 25758856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.